© 2002 by Heart
REVIEW
Transfer for primary angioplasty: who and how?
Institut de Cardiologie, Pitie-Salpetriere University Hospital, 47 Boulevard de lHopital, 75013 Paris, France
Correspondence to:
Correspondence to:
Dr G Montalescot, Institut de Cardiologie, Bureau 2236, Pitie-Salpetriere University Hospital, 47 Boulevard de lHopital, 75013 Paris, France;
gilles.montalescot{at}psl.ap-hop-paris.fr
Randomised trials have led to the conclusion that percutaneous coronary intervention (PCI) is the best reperfusion strategy for most patients with acute myocardial infarction (AMI). However, these trials have limited application to routine practice. Modern trials of mechanical reperfusion strategies need to take account of logistics, transfer times, and adjunctive drug treatment during transfer (facilitated PCI). Such PCI protocols need to be judged against very early thrombolysis with modern agents. This has been the thrust behind a series of recent studies addressing these "real world" issues in early AMI management
Keywords: transfer; primary angioplasty; stenting; glycoprotein IIb/IIIa antagonist
Abbreviations: AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; tPA, tissue-type plasminogen activator
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
